Le Lézard
Classified in: Science and technology
Subjects: CALENDAR OF EVENTS, Conference Calls/ Webcasts

VERSES® Announces Fireside Chat with Chief Scientist Professor Karl Friston


VANCOUVER, British Columbia, Feb. 07, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES" or the "Company"), a cognitive computing company specializing in next-generation intelligent agent systems, announces that on Thursday February 13th the Company will host a webinar discussion of "Intelligence in the Age of Agents" with Karl Friston, VERSES Chief Scientist, joined by VERSES CEO, Gabriel René, moderated by Olivier Oullier, renowned neuroscientist, strategist and investor.

This engaging discussion will explore:

To register for the webinar interested parties can use the following link: https://event.webinarjam.com/register/365/gp59xsk5

Atari, Inc. Atari and the Atari logo are registered trademarks owned by Atari Interactive, Inc. Mastermindtm is a registered trademark of Pressman Inc.

About VERSES

VERSES is a cognitive computing company building next-generation intelligent software systems modeled after the wisdom and genius of Nature. Designed around first principles found in science, physics and biology, our flagship product, Genius, is a suite of tools for machine learning practitioners to model complex dynamic systems and generate autonomous intelligent agents that continuously reason, plan, and learn. Imagine a Smarter World that elevates human potential through technology inspired by Nature. Learn more at verses.ai, LinkedIn, and X.

On behalf of the Company 

Gabriel René, Founder & CEO, VERSES AI Inc.

Press Inquiries: [email protected] 

Investor Relations Inquiries 

U.S., Matthew Selinger, Partner, Integrous Communications, [email protected] 415-572-8152

Canada, Leo Karabelas, President, Focus Communications, [email protected] 416-543-3120



These press releases may also interest you

at 17:52
Spring Clean Smarter with Dreame: Enjoy Up to 25% Off in Our Biggest Sale of the Season
Dreame Technology is celebrating the season with an exciting Spring Sale, offering up to 25% off on its latest flagship smart home cleaning products....

at 17:46
In-Licensing Opportunity: How a Pharma Leader Leveraged Scientific Innovation for Clinical and Commercial Success | DelveInsight
The objective was to assess dissolvable microneedle technology and identify top licensing partner companies with the right technological competencies, clinical capabilities, and commercial readiness using secondary and primary intelligence. The...

at 17:36
Ovative Group Reveals 2025 EMR Power Rankings, Empowering Marketers to Drive Omni Sales Impact
Ovative Group, a leading performance marketing and measurement firm, unveiled its highly anticipated 2025 EMR Power Rankings, providing marketers with essential data on which paid media channels drive the highest Enterprise Marketing Return (EMR). As...

at 17:31
CARVYKTI Continued Performance Reflects Growing Confidence in CAR-T Therapies for Multiple Myeloma | DelveInsight
DelveInsight's "CARVYKTI Market Size, Forecast, and Market Insight Report" highlights the details around CARVYKTI, a BCMA-directed, genetically modified autologous T-cell immunotherapy, which involves reprogramming a patient's T cells with a...

at 17:10
Novotech Named Best Contract Research Organization in Australia at Asia-Pacific Biopharma Excellence Awards 2025
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma companies an accelerated path to market, has been recognized as the Best Contract...

at 17:05
Growth Equity Firm PSG invests US $280 Million in Protecht
Protecht Group ("Protecht"), an Australian based leader in governance, risk, and compliance (GRC) solutions, today announces a US $280M investment from PSG Equity ("PSG"), a leading growth equity firm that specialises in partnering with software and...

More news about Science and technology...


News published on and distributed by: